INTEREST OF COMBINATION THERAPY WITH IMMUNOSUPPRESSIVE TREATMENT IN IBD PATIENTS IN LOSS OF RESPONSE TO INFLIXIMAB AND EXHIBITING VERY HIGH ANTI-INFLIXIMAB ANTIBODY (ATI) LEVELS.

Xavier Roblin  1     Emilie Del Tedesco  1     Laurent Biroulet  2     St├ęphane Paul  3    
1 Chu Saint Etienne, Saint Etienne, France
2 Chu Nancy, Nancy, France
3 Chu Saint Etiennne, Saint Etiennne, France

Conference
UEG Week 2014

Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing